Also trades as: SMSPHARMA.NS (NSE) · $vol 3M
SMSPHARMA.BO BSE
SMS Pharmaceuticals Limited
1W: -0.6%
1M: +27.7%
3M: +11.1%
YTD: +47.9%
1Y: +103.6%
3Y: +294.9%
5Y: +157.1%
₹475.80 ($4.94)
+4.20 (+0.89%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$13.6B
+18.2% ▲
5Y CAGR: +10.9%
Total Liabilities
$5.8B
+12.4% ▲
5Y CAGR: +7.5%
Shareholders Equity
$7.9B
+22.9% ▲
5Y CAGR: +13.9%
Cash & Investments
$461M
+10.8% ▲
5Y CAGR: +2.7%
Total Debt
$3.7B
+17.5% ▲
5Y CAGR: +7.5%
Net Debt
$3.2B
+18.5% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $466M | $74M | $360M | $416M | $461M |
| Short-Term Investments | $0 | $0 | $765K | $0 | $0 |
| Cash & ST Investments | $466M | $74M | $361M | $416M | $461M |
| Net Receivables | $485M | $1.5B | $2.4B | $2.0B | $2.2B |
| Inventory | $2.5B | $2.2B | $2.3B | $2.8B | $3.5B |
| Other Current Assets | $275M | $252M | $226M | $249M | $249M |
| Total Current Assets | $3.8B | $4.1B | $5.3B | $5.5B | $6.4B |
| Property, Plant & Equip. | $4.5B | $4.4B | $4.8B | $5.7B | $6.5B |
| Goodwill & Intangibles | $14M | $15M | $27M | $21M | $28M |
| Long-Term Investments | $215M | $115M | $109M | $117M | $375M |
| Other Non-Current Assets | $116M | $56M | $49M | $189M | $313M |
| Total Non-Current Assets | $4.8B | $4.7B | $5.0B | $6.0B | $7.2B |
| Total Assets | $8.6B | $8.8B | $10.3B | $11.5B | $13.6B |
| — Liabilities — | |||||
| Accounts Payable | $580M | $1.0B | $1.1B | $1.1B | $1.2B |
| Short-Term Debt | $1.1B | $1.3B | $1.6B | $1.7B | $1.9B |
| Deferred Revenue | $13M | $65M | $0 | $0 | $0 |
| Other Current Liabilities | $68M | $1M | $93M | $391M | $385M |
| Total Current Liabilities | $2.0B | $2.5B | $3.3B | $3.2B | $3.5B |
| Long-Term Debt | $1.5B | $1.2B | $1.2B | $1.4B | $1.7B |
| Other Non-Current Liab. | $16M | $14M | $12M | $12M | $12M |
| Total Non-Current Liabilities | $1.9B | $1.6B | $1.7B | $1.9B | $2.2B |
| Total Liabilities | $3.9B | $4.2B | $5.0B | $5.1B | $5.8B |
| — Equity — | |||||
| Common Stock | $85M | $85M | $85M | $89M | $94M |
| Retained Earnings | $3.0B | $2.9B | $3.2B | $3.8B | $4.7B |
| Accumulated OCI | $946M | $946M | $1.3B | $1.3B | $1.2B |
| Total Stockholders Equity | $4.7B | $4.6B | $5.4B | $6.4B | $7.9B |
| Total Liabilities & Equity | $8.6B | $8.8B | $10.3B | $11.5B | $13.6B |
| — Key Metrics — | |||||
| Total Debt | $2.6B | $2.5B | $2.8B | $3.1B | $3.7B |
| Net Debt | $2.2B | $2.5B | $2.4B | $2.7B | $3.2B |
| Total Investments | $215M | $115M | $110M | $117M | $375M |